Background/Aims: To examine whether chronic intake of vegetable protein added to animal protein diet affects renal hemodynamics or not, we studied effects of three kinds of diets containing various amounts of animal and vegetable protein with 1-week dietary program in each on renal hemodynamics. Methods: The crossover design of different amounts of vegetable protein added to the constant amount of animal protein was applied to two groups of 7 healthy individuals after the control dietary program. Renal function and 24 hours’ urinary albumin excretion rate (AER) were examined on every 7th day of three consecutive 1-week dietary programs. Results: Glomerular filtration rate (GFR; sodium thiosulphate clearance) and renal plasma flow (RPF) significantly decreased after decreasing the intake of animal protein by one third with keeping the amount of vegetable protein constant. The results when substituting vegetable protein for some of the animal protein in the diet without changing the total amount of protein were identical. The filtration fraction and AER did not change over the study periods regardless of dietary composition. Conclusion: The lack of an effect a 1-week intake of vegetable protein added to animal protein on GFR and RPF suggests that vegetable protein may be excluded from lists of restriction in low protein diet therapy in patients with renal insufficiency.

Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981;241:F85–93.
Hostetter TH, Meyer TW, Rennke HG, Brenner BM: Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 1986;30:509–517.
Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta analysis. Ann Intern Med 1996;124:627–632.
Dullaart RP, Beusekamp BJ, Meijer S, Van Doormaal JJ, Sluiter WJ: Long-term effects of protein restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993;16:483–492.
Percheron C, Colette C, Astre C, Monnier L: Effects of moderate changes in protein intake on urinary albumin excretion in type I diabetic patients. Nutrition 1995;11:345–349.
Nakamura H, Takasawa M, Kasahara S, Tsuda A, Momotsu T, Ito S, Shibata A: Effects of acute protein loads of different sources on renal function of patients with diabetic nephropathy. Tohoku J Exp Med 1989;159:153–162.
Nakamura H, Ito S, Ebe N, Shibata A: Renal effects of different types of protein in healthy volunteer subjects and diabetic patients. Diabetes Care 1993;16:1071–1075.
Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P, Borsato M, Sacerdoti D, Viberti G: Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990;38:136–144.
Toeller M, Buyken A, Heitkamp G, Bramswig S, Mann J, Milne R, Gries FA, Keen H and the EURODIAB IDDM Complications Study Group: Protein intake and urinary albumin excretion rates in the EURODIAB IDDM complications study. Diabetologia 1997;40:1219–1226.
Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Eng J Med 1982;307:652–659.
Isaksson B: Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 1980;33:4–5.
Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58–65.
Brodows RG, Nichols D, Shaker G, Kubasik NP: Evaluation of a new radioimmunoassay for urinary albumin. Diabetes Care 1986;9:189–193.
Bonnes RW, Taussky HH: On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem 1945;158:581–591.
Kupin WL, Cortes P, Dumler F, Feldkamp CS, Kilates MC, Levin NW: Effect on renal function of change from high to moderate protein intake in type I diabetic patients. Diabetes 1987;36:73–79.
Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH: Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 1995;47:1726–1731.
Apperloo AJ, de Zeeuw D, de Jong PE: A short-term antihypertensive treatment induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 1997;51:793–797.
Hansen HP, Christensen PK, Tauber Lassen E, Klausen A, Jensen BR, Parving HH: Low protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney Int 1999;55:621–628.
Jibani MM, Bloodworth LL, Foden E, Griffiths KD, Galpin OP: Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: Effects on albumin excretion rate and nutritional status. Diabetic Med 1991;8:949–953.
Narita T, Koshimura J, Suzuki K, Murata M, Meguro H, Fujita H, Kitazato H, Ito S: Effect of short-term glucemic control, low protein diet and administration of enalapril on renal hemodynamics and protein permselectivity in type 2 diabetic patients with microalbuminuria. Tohoku J Exp Med 1999;189:117–133.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.